Industry Insights - The third-party medical imaging service industry in China has significant potential, with a current penetration rate of only 1% compared to over 40% in the US, indicating a vast market opportunity [3][4] - AI technology is empowering the medical imaging sector through various applications, including equipment, auxiliary diagnosis, treatment support, and data quality control, which can enhance efficiency and reduce costs [3][4] - The third-party imaging centers serve as both producers of imaging data and application scenarios for AI, allowing them to generate additional revenue through licensing AI algorithms and data services [3][4] Company Overview - The company has established a one-stop ecosystem through three main business segments: imaging center services, imaging solution services, and Yimai Cloud services, which support and transform each other [3][4] - The imaging center business is the cornerstone of the company's revenue, accounting for over 60% of total income, and serves as a critical competitive advantage due to high market entry barriers [4] - The imaging solution business is rapidly growing, with a significant increase in users and high profitability potential, aiming for 30% of revenue from overseas markets within five years [4][5] - Yimai Cloud is a key component of the company's digital strategy, leveraging one of the largest and fastest-growing medical imaging databases in China to enhance data value [5] - The company plans to achieve revenues of 1.01 billion, 1.29 billion, and 1.59 billion yuan in 2025, 2026, and 2027, respectively, with net profits projected to reach 39 million, 83 million, and 141 million yuan during the same period [5]
【华创医药】一脉阳光（02522.HK）深度研究报告：AI赋能，第三方医学影像龙头发展加速